Ovarian cancer may be hard to detect in its early stages and has a high likelihood of recurrence even when treated. This is why sustained disease control becomes extremely crucial. Recently, the introduction of targeted therapies such as Olaparib 150mg tablet in ovarian cancer has completely revolutionized the management of the treatment and gives a new hopt to patients.
What Is the Role of Olaparib 150mg In Ovarian Cancer?
The tablet is a unique type of medicine and not an ordinary chemotherapeutic agent. This is because it works in a more intelligent way than conventional medicines by targeting the weaknesses of cancer cells. It is mostly prescribed to patients with ovarian cancer and those who have been treated with chemotherapy before. It is also usually prescribed as a maintenance drug, especially in patients with ovarian cancer who have been responding to chemotherapy treatment.
How The Tablet Works Differently To Other Drugs?
Contrary to most conventional methods, which target both healthy and cancerous cells, olaparib is a highly selective therapy. It inhibits the PARP enzyme, which the cancer cells use in order to repair their DNA. In cases of ovarian cancer, especially those characterized by BRCA mutations, the repair mechanism of cancer cells is already weak. Olaparib inhibits this mechanism even further, resulting in accumulation of DNA damage within the cancer cells. Gradually, the amount of damage increases to such an extent that cancer cells start dying.
When Do Doctors Recommend This Tablet?
Most of the healthcare experts recommend this medicine because of its several adavnatges over ovarian ancer treatment. Some are as follows:
- It work as a maintenance therapy after effective chemotherapy.
- Also use in recurrence of ovarian cancer.
- Recommended in advanced stages of ovarian cancer.
- People who have BRCA gene mutations.
How to Take The Medicine?
This medicine is orally administered, typically twice daily as per the doctor’s prescription. It must be taken consistently for optimal effects and long term disease control. The doctor can adjust the dosage depending on the patient’s reaction to the medication and based on the previous medical history.
Conclusion
The tablet Olaparib is a sign of a new approach in terms of personalization and treatment targeting for women suffering from ovarian cancer. This medication is aimed not only at treating the disease but at controlling it in order to improve the quality of life of a person.
FAQs
1. Who is Eligible for Taking This Medicine?
Generally, it is recommended to people suffering from ovarian cancer who have benefited from platinum-based chemotherapy or those having BRCA gene mutations.
2. Can Pregnant or breastfeeding women use this medicine?
No, the tablet may cause serious health issues to the infant or new born baby, hence pregnant or breastfeeding women should avoid using it.
